Publikationer 2012


Kurt Boman

  1. Wennberg P, Wensley F, Di Angelantonio E, Johansson L, Boman K, Rumley A, Lowe G, Hallmans G, Danesh J, Jansson JH. Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women. Thromb Res.2012 Jan;129(1):68-73. Epub 2011 Jun 8. PubMed PMID: 21641633.
  2. Boman K, Davidson T, Gustavsson M, Olofsson M, Renström GB, Johansson L. Telemedicine improves the monitoring process in anticoagulant treatment. J Telemed Telecare. 2012;18(6):312-6. Epub 2012 Aug 14. PubMed PMID: 22892374.
  3. Höglund N, Andersson J, Almroth H, Tornvall P, Englund A, Rosenqvist M, Jensen SM, Boman K. The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. Int J Cardiol. 2012 Jun 15. [Epub ahead of print] PubMed PMID: 22704860.
  4. Greve AM, Olsen MH, Bella JN, Lønnebakken MT, Gerdts E, Okin PM, Palmieri V, Boman K, Nieminen MS, Omvik P, Dahlöf B, Devereux RB, Wachtell K. Contrasting Hemodynamic Mechanisms of Losartan- vs. Atenolol-Based Antihypertensive Treatment: A LIFE Study. Am J Hypertens. 2012 Sep;25(9):1017-23. doi: 10.1038/ajh.2012.81. Epub 2012 Jun 14. PubMed PMID: 22695506.
  5. Johansson I, Nilsson L, Stegmayr B, Boman K, Hallmans G, Winkvist A. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J. 2012 Jun 11;11(1):40. [Epub ahead of print] PubMed PMID: 22686621.
  6. ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012 Jul 26;367(4):319-28. Epub 2012 Jun 11. PubMed PMID: 22686416.
  7. ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl  J Med. 2012 Jul 26;367(4):309-18. Epub 2012 Jun 11. PubMed PMID: 22686415.
  8. Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension. 2012 Jul;60(1):90-7. Epub 2012 May 29. PubMed PMID: 22647889.
  9. Brännström M, Boman K. A new model for integrated heart failure and palliative advanced homecare - rationale and design of a prospective randomized study. Eur J Cardiovasc Nurs. 2012 May 28. [Epub ahead of print] PubMed PMID: 22645405.
  10. Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Am Heart J. 2012 Apr;163(4):690-6. PubMed PMID: 22520536.
  11. Gerdts E, Okin PM, Boman K, Wachtell K, Nieminen MS, Dahlöf B, Devereux RB. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy. Am J Hypertens. 2012 Jun;25(6):678-83. doi: 10.1038/ajh.2012.31. Epub 2012 Mar 29. PubMed PMID: 22456225.
  12. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Devereux RB, Køber L, Ray S, Willenheimer R, Wachtell K. Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study. J Am Coll Cardiol. 2012 Mar 27;59(13):1142-9. PubMed PMID: 22440214.
  13. Holme I, Pedersen TR, Boman K, Egstrup K, Gerdts E, Kesäniemi YA, Malbecq W, Ray S, Rossebø AB, Wachtell K, Willenheimer R, Gohlke-Bärwolf C. A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis. Heart. 2012 Mar;98(5):377-83. Epub 2011 Dec 8. PubMed PMID: 22155702.
  14. Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation. 2012 Jan 17;125(2):346-53. Epub 2011 Dec 6. PubMed PMID: 22147903.
  15. Remmets JB, Olofsson M, Stenlund H, Boman K. How many systolic and diastolic variables must be measured in elderly patients with symptoms of heart failure? World Journal of Cardiovascular diseases, 2012, 2, 102-109
  16. Pourhamidi K, Dahlin LB, Boman K, Rolandsson O. Heat shock protein 27 is associated with better nerve function and fewer signs of neuropathy. Diabetologia. 2011 Dec;54(12):3143-9. Epub 2012 Sep 10. PubMed PMID: 21909836.
  17. Brännström M, Hägglund L, Fürst CJ, Boman K. Unequal care for dying patients in Sweden: a comparative registry study of deaths from heart disease and cancer. Eur J Cardiovasc Nurs. 2012 Dec;11(4):454-9. doi: 10.1016/j.ejcnurse.2011.06.007.Epub 2012 Apr 4. PubMed PMID: 21764639.
  18. Burström M, Brännström M, Boman K, Strandberg G. Life experiences of security and insecurity among women with chronic heart failure. J Adv Nurs. 2012 Apr;68(4):816-25. doi: 10.1111/j.1365-2648.2011.05782.x. Epub 2011 Jul 7. PubMed  PMID: 21733141.
  19. De Marco M, Gerdts E, Casalnuovo G, Migliore T, Wachtell K, Boman K, Dahlöf B Olsen MH, Kizer JR, Devereux RB, de Simone G. Mitral Annular Calcification and Incident Ischemic Stroke in Treated Hypertensive Patients: The LIFE study. Am J Hypertens. 2013 Feb 7. [Epub ahead of print] PubMed PMID: 23391619.


Jan-Håkan Jansson

  1. Hernestål-Boman J, Norberg M, Jansson JH, Eliasson M, Eriksson JW, Lindahl B, Johansson L. Signs of dysregulated fibrinolysis precede the development of type 2diabetes mellitus in a population-based study. Cardiovasc Diabetol. 2012 Dec18;11:152. doi: 10.1186/1475-2840-11-152. PubMed PMID: 23249721; PubMed Central PMCID: PMC3538597.
  2. Wennberg M, Strömberg U, Bergdahl IA, Jansson JH, Kauhanen J, Norberg M, Salonen JT, Skerfving S, Tuomainen TP, Vessby B, Virtanen JK. Myocardial infarction in relation to mercury and fatty acids from fish: a risk-benefit analysis based on pooled Finnish and Swedish data in men. Am J Clin Nutr. 2012 Oct;96(4):706-13. Epub 2012 Aug 15. PubMed PMID: 22894940.
  3. Eriksson M, Carlberg B, Jansson JH. Comparison of blood pressure measurements  between an automated oscillometric device and a Hawksley random-zero sphygmomanometer in the northern Sweden MONICA study. Blood Press Monit. 2012 Aug;17(4):164-70. doi: 10.1097/MBP.0b013e328356ef58. PubMed PMID: 22781634.
  4. Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Hallqvist J, Hedblad B, Jansson JH, Nilsson P, Pedersen N, Trolle Lagerros Y, Ostergren PO, Magnusson C. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012 Oct;27(10):771-9 doi: 10.1007/s10654-012-9704-8. Epub 2012 Jun 22. PubMed PMID: 22722951.
  5. Crowe FL, Key TJ, Appleby PN, Overvad K, Schmidt EB, Egeberg R, Tjønneland A,  Kaaks R, Teucher B, Boeing H, Weikert C, Trichopoulou A, Ouranos V, Valanou E, Masala G, Sieri S, Panico S, Tumino R, Matullo G, Bueno-de-Mesquita HB, Boer JM,  Beulens JW, van der Schouw YT, Quirós JR, Buckland G, Sánchez MJ, Dorronsoro M, Huerta JM, Moreno-Iribas C, Hedblad B, Jansson JH, Wennberg P, Khaw KT, Wareham N, Ferrari P, Illner AK, Chuang SC, Norat T, Danesh J, Riboli E. Dietary fibre intake and ischaemic heart disease mortality: the European Prospective Investigation into Cancer and Nutrition-Heart study. Eur J Clin Nutr. 2012 Aug;66(8):950-6. doi: 10.1038/ejcn.2012.51. Epub 2012 May 23. PubMed PMID: 22617277.
  6. Nilsson LM, Winkvist A, Brustad M, Jansson JH, Johansson I, Lenner P, Lindahl  B, Van Guelpen B. A traditional Sami diet score as a determinant of mortality in  a general northern Swedish population. Int J Circumpolar Health. 2012 May 4;71(0):1-12. doi: 10.3402/ijch.v71i0.18537. PubMed PMID: 22584519; PubMed Central PMCID: PMC3417469.
  7. Lindmark K, Jansson JH. [Comparison Riks-HIA--medical records gave no basis for care improvement. Difficult to explain the lower number of reperfusion in ST  elevation infarction in the Norrland's counties]. Lakartidningen. 2012 Jan 25-31;109(4):158-60. Swedish. PubMed PMID: 22482224.
  8. Krivospitskaya O, Elmabsout AA, Sundman E, Söderström LA, Ovchinnikova O, Gidlöf AC, Scherbak N, Norata GD, Samnegård A, Törmä H, Abdel-Halim SM, Jansson JH, Eriksson P, Sirsjö A, Olofsson PS. A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis. Mol Med. 2012 May 9;18:712-8.  doi: 10.2119/molmed.2012.00094. PubMed PMID: 22415012; PubMed Central PMCID: PMC3388133.
  9. Nilsson LM, Winkvist A, Eliasson M, Jansson JH, Hallmans G, Johansson I, Lindahl B, Lenner P, Van Guelpen B. Low-carbohydrate, high-protein score and mortality in a northern Swedish population-based cohort. Eur J Clin Nutr. 2012 Jun;66(6):694-700. doi: 10.1038/ejcn.2012.9. Epub 2012 Feb 15. PubMed PMID: 22333874.
  10. Lind M, Boman K, Johansson L, Nilsson TK, Järvholm LS, Jansson JH. Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. J Intern Med. 2012 Mar;271(3):239-46. doi: 10.1111/j.1365-2796.2011.02418.x. Epub 2011 Jul 26. PubMed PMID: 21707795.
  11. Wennberg P, Wensley F, Di Angelantonio E, Johansson L, Boman K, Rumley A, Lowe G, Hallmans G, Danesh J, Jansson JH. Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women. Thromb  Res. 2012 Jan;129(1):68-73. doi: 10.1016/j.thromres.2011.05.015. Epub 2011 Jun 8. PubMed PMID: 21641633.
  12. Wiklund P, Nordström A, Jansson JH, Weinehall L, Nordström P. Low bone mineral density is associated with increased risk for myocardial infarction in men and women. Osteoporos Int. 2012 Mar;23(3):963-70. doi: 10.1007/s00198-011-1631-0. Epub 2011 Apr 20. PubMed PMID: 21505909.
Stöd vår forskning redan idag

Så hjälper du till

Stiftelsen vill inspirera och stödja yngre men även äldre läkare, sjuksköterskor, apotekare med flera till att forska inom områdena medicin och omvårdnad inom Skellefteå sjukvård (kommunerna Skellefteå och Norsjö).

Postgiro & Bankgiro

Stöd vår verksamhet genom att sätta in pengar på följande Post- och Bankgiro:

Stiftelsens postgiro 444 81 29-9
Stiftelsens bankgiro 710-9721
Stiftelsens swish 1233351574
Org nr 89 47 01-2384

Dela vår hemsida

Hjälp vår stiftelse och våra forskare genom att sprida vår sida vidare via sociala medier.
Information om cookies